A new study from the University of Bath has found that for older adults with atrial fibrillation (AF), stopping blood ...

They also base their decisions to stop anticoagulants on past experiences with people who took the anticoagulant warfarin, Mitchell said. Up until 2012, warfarin was the only option to treat Afib.

Opens in a new tab or window For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban.

Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its incidence increases with age. Current data suggest that anticoagulation with warfarin or dabigatran is far superior to ...

A new study suggests that the benefits of prescribing anticoagulation drugs to certain older people outweigh the potential risks. For patients with atrial fibrillation, the risk of stroke or heart ...

The results showed that patients taking diltiazem had a 20% higher risk of being hospitalized or dying due to serious ...

In this randomized controlled trial, abelacimab led to significantly lower rates of major or clinically relevant nonmajor ...

In this randomized controlled trial, among patients with atrial fibrillation requiring anticoagulation therapy, asundexian ...

Discover how botanical and nutrient therapies provided adjunctive support for a 76-year-old patient with treatment-resistant ...

Opens in a new tab or window A population-based cohort study found an association between bleeding events in Afib patients on oral anticoagulation and cancer diagnoses. In cases where cancer was ...

For people with HIV and atrial fibrillation (Afib or AF), certain oral anticoagulants (OACs) may carry a higher bleeding risk ...